Michael Vasconcelles's most recent trade in Kura Oncology Inc was a trade of 52,000 Option to purchase common stock done . Disclosure was reported to the exchange on Sept. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kura Oncology Inc | Michael J. Vasconcelles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 52,000 | 52,000 | - | - | Option to purchase common stock | |
Kura Oncology Inc | Michael J. Vasconcelles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 17,333 | 17,333 | - | - | Option to purchase common stock | |
Immunogen, Inc. | J. Michael Vasconcelles | EVP R&D & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 16.01 per share. | 29 Dec 2023 | 1,327 | 1,327 (0%) | 0% | 16.0 | 21,245 | Common Stock |